# Alamar Biosciences (ALMR) — Earnings

ALMR · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/almr/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | −$0.22 |
| EPS estimate | −$0.31 |
| EPS surprise | +28.55% |
| Revenue surprise | +13.69% |
| Revenue | $29.4M |
| Revenue estimate | $25.9M |
| Reported | Aug 10, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/2104204/000119312526343003/ck0002104204-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/45f45c3a-cdb7-d27e-5181-c12beb4db1e6.html) |

Alamar Biosciences reported Q2 2026 results on August 10, 2026. It posted a loss of $0.22 per share, narrower than the estimated $0.31 loss, a 28.55% beat. Revenue was $29.4 million, 13.69% above the $25.9 million estimate.

The record is short. The table holds only two quarters, so there is no year-earlier quarter to compare with and no full year to total. In Q1 2026, reported May 8, 2026, Alamar lost $1.74 per share, slightly worse than the $1.71 loss expected, on revenue of $26.0 million that matched its estimate. From Q1 to Q2, revenue rose and the loss per share narrowed sharply. Both quarters in the table were losses, adding up to $1.96 per share for the first half of 2026.

The two reports came 94 days apart. If the company keeps a quarterly rhythm, Q3 2026 results would follow around early-to-mid November 2026. With so little history, the next report will be the first chance to see whether the narrower loss per share in Q2 carries into a third quarter, and whether revenue keeps growing from one quarter to the next.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 10, 2026 | −$0.31 | −$0.22 | 28.55% | $25.9M | $29.4M |
| Q1 2026 | May 8, 2026 | −$1.71 | −$1.74 | -1.75% | $26.0M | $26.0M |

## Frequently Asked Questions

### When did Alamar Biosciences (ALMR) last report earnings?

Alamar Biosciences last reported on Aug 10, 2026, covering fiscal Q2 2026.

### Did ALMR beat earnings estimates?

Yes. Alamar Biosciences reported EPS of −$0.22 for Q2 2026 against a −$0.31 estimate — a 28.55% beat.

### How much revenue did ALMR report last quarter?

Alamar Biosciences reported $29.4M in revenue for Q2 2026, against a consensus estimate of $25.9M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).